Biotech's 2004 IPO Hopefuls Expecting Large Step-ups
This article was originally published in Start Up
Executive Summary
Biotech companies waiting in the IPO pipeline have one thing in common: on average, they're expecting step-ups far in excess of those for companies which have already gone public this year.